Biocon Biologics
Dwight Hanshew is the Chief Quality Officer at Biocon Biologics, bringing extensive experience in quality, compliance, data integrity, and operations. With a background in leading quality and compliance functions for pharmaceutical companies such as Cipla USA and Mylan, Dwight has a proven track record of building global quality management systems and driving initiatives to enhance customer service. Dwight has also provided advisory services to international clients in compliance, operations, and leadership. Dwight's educational background includes a Master's degree in Analytical Chemistry and an MBA Essentials from the University of Pittsburgh Katz Graduate School of Business.
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics